Andrew M. Dahl is SVP, Corporate Controller of Edwards Lifesciences Corp. Currently has a direct ownership of 9,183 shares of EW, which is worth approximately $792,492. The most recent transaction as insider was on Nov 13, 2025, when has been sold 1,160 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.18K
13.29% 3M change
95.8% 12M change
Total Value Held $792,492

Andrew M. Dahl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 13 2025
BUY
Grant, award, or other acquisition
-
1,160 Added 11.22%
9,183 Common Stock
Sep 13 2025
SELL
Payment of exercise price or tax liability
$20,323 $77.57 p/Share
262 Reduced 3.2%
7,926 Common Stock
May 08 2025
BUY
Grant, award, or other acquisition
-
3,335 Added 29.15%
8,106 Common Stock
Feb 22 2025
SELL
Payment of exercise price or tax liability
$12,900 $73.3 p/Share
176 Reduced 3.62%
4,684 Common Stock
Sep 13 2024
BUY
Grant, award, or other acquisition
-
2,920 Added 38.37%
4,690 Common Stock
AMD

Andrew M. Dahl

SVP, Corporate Controller
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW